Glucocorticoid Therapy with Dexamethasone and Hydrocortisone

Introduction to Glucocorticoid Therapy

The American Society of Anesthesiologists recommends that dexamethasone and hydrocortisone can be given together in specific clinical situations, such as primary adrenal insufficiency, but this is generally unnecessary and potentially harmful due to excessive glucocorticoid exposure 1, 2, 3

Dexamethasone has extremely high potency, with 8 mg of dexamethasone equal to approximately 200 mg of hydrocortisone in glucocorticoid effect, providing more than adequate coverage for most stress situations over 24 hours, according to the American College of Clinical Pharmacology 1, 2, 3
The overlapping mechanism of action of dexamethasone and hydrocortisone, which work through the same glucocorticoid receptor pathways, means that combining them simply adds to the total glucocorticoid burden without providing additional therapeutic benefit in most scenarios, as stated by the American Society of Anesthesiologists 1, 2

In patients with primary adrenal insufficiency, dexamethasone alone is inadequate for stress coverage because it completely lacks mineralocorticoid activity, and hydrocortisone must be added to provide the essential mineralocorticoid replacement, according to the Endocrine Society 1, 2, 3
Hydrocortisone is structurally identical to cortisol and binds both mineralocorticoid and glucocorticoid receptors, whereas dexamethasone binds only glucocorticoid receptors, as noted by the American Academy of Pediatrics 4, 5, 6

For patients requiring perioperative glucocorticoid supplementation, the American Society of Anesthesiologists recommends selecting either dexamethasone or hydrocortisone based on the clinical situation, with a single 8 mg dose of dexamethasone providing equivalent coverage to 200 mg hydrocortisone for 24 hours due to its long half-life 1, 2, 3
If using hydrocortisone, it should be administered via continuous IV infusion or intermittent dosing every 6-8 hours, as its half-life is only 90 minutes, according to the American College of Clinical Pharmacology 1, 2, 3

The American Academy of Pediatrics recommends avoiding combining dexamethasone and hydrocortisone in neonates and children except under extraordinary circumstances, as high-dose dexamethasone can cause hippocampal neuronal degeneration and necrosis in animal models 4, 5, 6

The American Society of Anesthesiologists suggests identifying the indication for glucocorticoid therapy, determining adrenal status, and selecting a single agent based on pharmacokinetics, with dexamethasone being long-acting and having no mineralocorticoid activity, and hydrocortisone being short-acting and having mineralocorticoid activity 1, 2, 3
The Endocrine Society recommends against reflexively adding hydrocortisone to dexamethasone in patients with secondary adrenal insufficiency or those on chronic glucocorticoid therapy, and against using dexamethasone alone in primary adrenal insufficiency without adding mineralocorticoid replacement 1, 2, 3